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Abstract 
 Intramedullary stabilization is frequently used to treat long bone fractures. Implants 
usually remain unless complications arise. Since implant removal can become 
technically very challenging with the potential to cause further tissue damage, 
biodegradable materials are emerging as alternative options. Magnesium (Mg)-based 
biodegradable implants have a controllable degradation rate and good tissue 
compatibility, which makes them attractive for musculoskeletal research. Here we 
report for the first time the implantation of intramedullary nails made of an Mg alloy 
containing 2% silver (Mg2Ag) into intact and fractured femora of mice. Prior in vitro 
analyses revealed an inhibitory effect of Mg2Ag degradation products on osteoclast 
differentiation and function with no impair of osteoblast function. In vivo, Mg2Ag 
implants degraded under non-fracture and fracture conditions within 210 days and 
133 days, respectively. During fracture repair, osteoblast function and subsequent 
bone formation were enhanced, while osteoclast activity and bone resorption were 
decreased, leading to an augmented callus formation. We observed a widening of 
the femoral shaft under steady state and regenerating conditions, which was at least 
in part due to an uncoupled bone remodeling. However, Mg2Ag implants did not 
cause any systemic adverse effects. These data suggest that Mg2Ag implants might 
be promising for intramedullary fixation of long bone fractures, a novel concept that 
has to be further investigated in future studies. 
 
Keywords: Mg2Ag alloy, Biodegradation, Intramedullary fracture fixation, Bone 
healing, Callus formation 
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1. Introduction 
 Fractures of the femoral and tibia shaft often occur in response to high energy 
trauma and are preferentially treated by an intramedullary nail that supports the 
fracture zone and facilitates bone healing [1–3]. The intramedullary stabilization 
usually remains since implant removal in general and extraction of a nail in particular 
can be very time-consuming, cumbersome and may cause further tissue damage, re-
fracture and other subsequent problems [4–6]. Thus, the second surgery imposes a 
potential risk to the patient and causes additional costs. However, pain, dysesthesia, 
a broken nail, infection, pseudarthrosis or the need for implanting a hip or knee 
prosthesis later in life may require removal of the intramedullary nail [5,6]. Thus, 
biodegradable implants represent an attractive alternative to replace conventional 
implants. Among the various biodegradable materials, magnesium (Mg) and Mg-
containing alloys have a long history in the musculoskeletal field [7]. Based on their 
high biocompatibility, biodegradability, and similar mechanical properties to bone, 
many studies investigated the use of Mg and its alloys for applications in orthopedic 
surgery [8–17]. In addition to its favorable mechanical properties, Mg has been 
shown to increase osteoblast differentiation in vitro [18,19] and to induce new bone 
formation in vivo [13], demonstrating a high osteogenic potential. Furthermore, as 
screws for hallux valgus surgery, Mg-based implants are already in use for clinical 
applications [10,20]. However, these implants are much smaller than intramedullary 
nails and are not entirely surrounded by bone marrow, an environment that might 
affect implant degradation and tissue response. 
 Among the challenges with Mg implants are the degradation rate and the 
biocompatibility [13–15]. For instance, Mg-Calcium alloys are biocompatible but 
degrade quite rapidly [21,22]. Mg-Fluoride coating has been reported to reduce the in 
vivo degradation rate of Mg implants and rare earth metals that are frequently used 
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as alloy materials for Mg can cause cytotoxic effects [23,24]. Recently, members of 
our consortium reported a novel Mg alloy containing 2% silver (Mg2Ag), which was 
cast and treated by a solidification cooling process, resulting in appropriate 
mechanical properties and a rather low degradation rate. Furthermore, in vitro 
investigations of this alloy showed favorable antibacterial effects and no cytotoxicity 
to human osteoblasts [25]. 
 To investigate the in vivo degradation of this novel material as well as its impact on 
bone remodeling and fracture healing, we implanted Mg2Ag intramedullary nails into 
mice with and without a femoral shaft fracture, followed by an analysis of in vivo 
degradation and tissue response under steady-state and bone healing conditions. 
Degradation of Mg2Ag alloys in vivo occurred without adverse effects but faster than 
in vitro. Mice were overall healthy and no adverse effects on body weight or kidney, 
liver, muscle, or spleen were observed. Radiographs and bone histomorphometry 
revealed that in comparison to steel implants, fractures supported by Mg2Ag 
intramedullary nails demonstrated a decreased bone resorption while bone formation 
was increased, leading to a significantly bigger callus during the first 21 days of 
fracture healing. These results demonstrate that fixation of long bone shaft fractures 
by intramedullary Mg2Ag nails might be a promising concept for further investigation. 
 
2. Materials and methods 
2.1. Mg2Ag implant preparation 
 Production of the Mg2Ag (2% Ag, wt/wt) alloy was performed by permanent mold 
casting using pure (99.99%) Mg and pure (99.99%) Ag granules. Briefly, molten Mg 
was maintained at 720°C and pre-heated Ag (150°C) was added under continuous 
stirring (200 rpm) for 15 min. The melt was poured into a mild steel mold pre-heated 
to 550°C. For better separation of castings from the mold, hexagonal boron nitride 
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was used as mold release agent. In one casting, 6 ingots with a diameter of 30 mm 
and a length of >170 mm were produced. During the casting process cover gas (Ar + 
0.5% SF6) was applied. Ingots were cut to a length of 80 mm and trimmed to a 
diameter of 28 mm. Next, the alloy was homogenized in Ar (6 h at 420°C), followed 
by an extrusion at 370°C with an extrusion ratio of 1/16 from a diameter of 28 mm to 
3 mm. The extrusion speed was 4.5 mm/s. For wire production, the extruded rods 
were cut to 90 mm length and drawn by hand from a diameter of 3 mm to the final 
diameter of 0.8 mm in 0.05 mm increments. Prior to each drawing step, wires were 
heated to 300°C for 45 min until a diameter of 1.6 mm was reached. At smaller 
diameters the heating time was reduced to 15 min. Standard drawing dies, pliers, 
and draw wax as lubricant were used on a drawing bench. 
 
2.2. Implant characterization 
 Composition of the alloy was determined by energy-dispersive X-ray spectroscopy 
analysis (XRF) (Bruker Explorer S4, Bruker AXS GmbH, Karlsruhe, Germany). 
 
2.3. In vitro degradation of Mg2Ag implants and quantification of osmolality and pH 
 Mg2Ag wires of a diameter of 0.8 mm and a length of 20 mm were incubated in 3 
ml DMEM containing 10% fetal bovine serum (FBS) at cell culture conditions (37°C, 
5% CO2, 95% humidity). Initial weight was determined and compared to the weight 
after 7 days of incubation. The average in vitro degradation rate was calculated using 
the weight differences of 6 independent samples. During the 7 days of incubation, 
changes in pH and osmolality of the supernatant were determined using a pH meter 
and a Gonotec 030D cryoscopic osmometer (Gonotec, Berlin, Germany), 
respectively. 
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2.4. Preparation of medium conditioned with Mg2Ag implant degradation products 
 Mg2Ag degradation products were prepared as described previously [26]. Briefly, 
Mg2Ag disks of 1 cm in diameter were immersed for 24 h in α-MEM containing 10% 
FBS and maintained under cell culture conditions (37°C, 5% CO2, 95% humidity). 
Conditioned medium (CM) enriched with Mg2Ag degradation products was added to 
osteoblast and osteoclast cultures at a final concentration of 20%, 10% or 3.3%. Mg 
concentration in the CM was determined by the xylidylblue-I chromogenic method 
according to the manufacturers instructions (Mg Assay Kit, Biomol GmbH, Hamburg, 
Germany). The effect of the CM on cell differentiation and function was compared to 
normal differentiation medium as control. 
 
2.5. Osteoblast and osteoclast cultures 
 Long bone osteoblasts and bone marrow-derived osteoclast precursors were 
isolated from ten-week old C57Bl/6J wild type mice according to standard protocols 
[27,28]. Briefly, tibiae and femora were harvested and cleaned with a forceps and 
scalpel to remove adjacent soft tissues. Epiphyses were cut and bone marrow was 
flushed to obtain osteoclast precursor cells. Cells were then seeded into 10 cm² 
dishes with α-MEM containing 10% FBS and 1% Penicillin/Streptomycin (P/S). After 
incubation for 3 h, non-adherent osteoclast precursors were transferred into a new 10 
cm² dish and cultured in α-MEM supplemented with 10% FBS and 1% P/S for 2 days 
in the presence of 100 ng/ml macrophage colony stimulating factor (M-CSF, 
PeproTech, INC, Rocky Hill, NJ, USA). Next, osteoclast precursors were transferred 
into 96-well plates at a density of 45.000 cells/cm2 and were cultured in α-MEM with 
10% FBS and 1% P/S containing 25 ng/ml M-CSF and 100 ng/ml recombinant 
human receptor activator of NF-κB Ligand (RANKL, PeproTech, INC, Rocky Hill, NJ, 
USA). Mature, multinucleated osteoclasts formed after 4 days in culture and were 
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visualized by staining for tartrate resistant acid phosphatase (TRAP) activity. TRAP 
activity was detected in osteoclasts fixed by 4% neutral buffered formalin. For the 
staining, a sodium acetate buffer containing sodium tartrate (pH=5) and naphthol-
ASMX-phosphate as well as fast red violet as substrates was used. The number and 
the size of the osteoclasts were quantified using the Osteomeasure system 
(OsteoMetrics, Decatur, GA, USA). Pit formation, a measure of osteoclast function, 
was determined by seeding 45.000 osteoclast precursors/cm2 into 96-well plates 
containing dentin slices. Cells were differentiated in α-MEM containing 10% FBS, 1% 
P/S, 25 ng/ml M-CSF and 100 ng/ml RANKL. After 6 days of differentiation, cells 
were removed from dentin slices by incubation in 20% bleach for 5 min. Resorption 
pits were stained with 1% toluidine blue at pH 4.5. The area and the number of 
resorption pits were quantified using the Osteomeasure system. 
 Long bone envelopes remaining after flushing of the bone marrow were used for 
osteoblast outgrow cultures. Briefly, bones were cut into 1-2 mm2 pieces and 
digested in 1 ml α-MEM containing 2 mg/ml collagenase A (Roche Diagnostics, 
Indianapolis, IN, USA) for 2 h at 37°C for fibroblast removal. Bone pieces were then 
placed in α-MEM supplemented with 10% FBS and 1% P/S for 7 days to allow 
osteoblasts to outgrow onto tissue culture plastic. Next, osteoblasts were seeded at a 
density of 10.000 cells/cm2 into 96-well plates. Osteoblasts were then differentiated in 
the presence of 50 µg/mL L-ascorbic acid (Sigma Aldrich, St. Louis, MO, USA) and 5 
mM β-glycerol phosphate (EMD Millipore Corp., Billerica, MA, USA). Next, CM was 
added at a relative concentration of 3.3%, 10% or 20%. Non-supplemented culture 
medium served as control. Medium was changed every 2 days. Osteoblast 
differentiation was determined by staining of alkaline phosphatase (ALP) activity on 
day 7. For this purpose, cells were fixed with 4% neutral buffered formalin and 
stained in Tris-HCl buffer containing naphthol AS-MX and fast blue at 37°C. 
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2.6. Implantation of Mg2Ag pins and femoral fractures 
 All animal work was conducted at the University Medical Center Hamburg-
Eppendorf according to the German law after approval by the local authorities 
(animal protocol number: 102/14). Ten-week old male C57Bl/6J wild type mice were 
used for in vivo studies. To determine the in vivo degradation of Mg2Ag implants, we 
implanted Mg2Ag pins into the non-fractured right femur of mice. These mice were 
compared to mice that received a steel implant or no implant as controls. All implants 
were inserted into the right femur in a minimally invasive manner after skin excision 
over the knee joint and perforation of the cortical bone at the inter-condylar notch 
using a 21-gauge needle. The implants had a diameter of 0.8 mm and were cut to a 
length that allowed the implant to be located fully underneath the surface of the 
articular cartilage. The skin was closed using a surgical suture. Mice were placed on 
a warm pad with access to pain relieve medication while recovering from anesthesia. 
Animals were examined by day 30, 60 and 210 after implantation with 4 mice per 
group and time point. 
 In order to investigate the degradation of Mg2Ag pins under fracture repair 
conditions and to determine the effects of the implants on bone remodeling during 
bone healing, a model of an open femoral shaft fracture was used. Briefly, animals 
were anesthetized using a combination of ketamine (120 mg/kg body weight) and 
xylazine in saline (16 mg/kg body weight). At the lateral side of the right femur, an 
incision of 8 mm length was placed along the femoral shaft and muscles were gently 
pushed aside to expose the femur. Next, an incision was placed over the right knee 
joint and the cortical bone was perforated at the inter-condylar notch using a 21-
gauge needle, followed by the insertion of a Mg2Ag or steel pin into the distal femur. 
The femur was then fractured in the mid-shaft region using a bone cutter. Implants 
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were moved forward over the fracture into the proximal femur. Skin incisions were 
then sutured. Animals were recovered from anesthesia on a warm pad with access to 
pain relieve medication. Mice were injected with calcein and demeclocycline (each at 
40 mg/kg body weight) 5 days and 2 days prior to sacrifice, respectively, to label 
active surfaces of bone formation as a surrogate of osteoblast activity. By day 7, 14, 
21 and 133 after fracture, mice were analyzed with 6 to 11 animals per group and 
time point. 
 
2.7. X-ray and micro-computed tomography 
 Degradation of the Mg2Ag implants and fracture healing were followed by X-ray 
imaging with life animals under anesthesia at the indicated time points using a X-ray 
imager (Faxitron Xray corporation, Tucson, USA). Images were obtained at 36 kV 
with 4 s exposure time. 
 Micro-computed tomography (µCT) imaging was performed as a more sensitive 
approach to determine implant degradation and fracture healing. Briefly, femora were 
harvested and fixed in 4% neutrally buffered formalin for 48 h prior to storage in 70% 
ethanol. Scans were obtained using a Scanco VivaCT 80 scanner (Scanco Medical 
AG, Brüttisellen, Switzerland) at 70 kV, 114 µA, 16.5 µm/voxel resolution, 400 ms 
integration time and a threshold of 326 mg HA/ccm. Three-dimensional images were 
reconstructed using Imaris software 8.0 (Bitplane, Concord, MA, USA). 
 
2.8. Histological analysis 
 At the indicated time points of analysis, femora and several organs including liver, 
spleen, kidney, and rectus femoris muscle adjacent to the surgical site were 
harvested. All samples were fixed in 4% neutral buffered formalin for 48 h. Soft 
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tissues were dehydrated and embedded in paraffin. Sections of 5 µm thickness were 
prepared and stained with haematoxylin and eosin. 
 Bones were prepared for histology as described previously [29]. Briefly, bones 
were cleaned from surrounding soft tissue and steel implants were removed. Next, 
bones were dehydrated to absolute ethanol, followed by infiltration and embedding in 
methyl methacrylate. Longitudinal sections of 5 µm thickness were prepared at the 
central plane and stained by von Kossa/van Gieson, Toluidine blue, Masson Goldner 
trichrome, or mounted unstained. Histomorphometry of bone sections was performed 
using ImageJ and the Osteomeasure system. The particle analysis function of 
ImageJ was applied to determine the amount of bone in the callus using von 
Kossa/van Gieson-stained sections. For all other quantifications, the Osteomeasure 
system was used according to ASBMR guidelines where applicable [30]. Toluidine 
blue-stained sections were used to quantify the callus area and the amount of 
cartilage within the callus. Furthermore, Toluidine blue and Masson Goldner-stained 
sections were used to determine cellular parameters at the periosteal elevation site 
of the callus. In addition, unstained sections were subjected to dynamic 
histomorphometry to quantify bone formation rates at the periosteal elevation site of 
the callus. 
 
2.9. Statistics 
 IBM SPSS statistics software 21 was used for statistical analysis. Student’s t-test 
was applied to compare two independent experimental groups. Multiple groups were 
analyzed by one-way ANOVA with Tukey's post-hoc test. For all statistical 
comparisons, p-values ≤ 0.05 were considered statistically significant. 
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3. Results 
3.1. Alloy composition and in vitro degradation 
 
3.1.1. Analysis of Mg2Ag implants 
 Implant characterization by XRF revealed a content of 1.94 ± 0.05% (wt/wt) Ag. 
Impurities due to the natural composition of Mg, Ag and the alloying process were 
minor with 22.3 ± 2.4 ppm Fe, 20 ± 2.2 ppm Cu, 14.5 ± 1.1 ppm Ni, and 0.43 ± 0.03 
ppm Be. 
 
3.1.2. In vitro degradation, osmolality and pH 
 In vitro degradation of Mg2Ag implants was investigated during a time course of 7 
days. The surface of the implant was smooth by day 0 (Fig. 1a, upper panel) and 
became rough within 7 days (Fig. 1b, lower panel). The corrosion rate was 
determined as 0.473 ± 0.038 mm/year. During the 7 days of degradation, the 
osmolality of the medium increased only very modestly from 0.328 osmol/kg to 0.359 
± 0.003 osmol/kg, without reaching statistical significance (Fig. 1b). No significant 
changes in pH were detected, which remained stable during the course of the 
experiment (Fig. 1c). 
 
3.2. Effect of degradation products on bone cell differentiation and function 
 
3.2.1. Osteoblast differentiation 
 To determine the effect of Mg2Ag implant degradation products on osteoblast 
differentiation, mouse long bone osteoblasts were cultured with 3.3%, 10% and 20% 
medium conditioned with Mg2Ag implant degradation products, which corresponds to 
Mg concentrations of 0.22 mg/ml, 0.64 mg/ml and 1.28 mg/ml. Analysis of osteoblast 
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differentiation was determined after 7 days in culture by staining for ALP activity. The 
increasing amount of CM did not affect ALP activity, demonstrating that Mg2Ag 
degradation products had no influence on osteoblast differentiation in vitro (Fig. 1d). 
 
3.2.2. Osteoclast differentiation and function 
 Differentiation of murine osteoclast precursors into mature osteoclasts was 
investigated by quantifying the number and the size of tartrate-resistant acid 
phosphatase (TRAP)-positive cells that had more than three nuclei. These assays 
revealed that the numbers of TRAP-positive multinucleated osteoclasts as well as the 
size of these cells were reduced by an increasing amount of CM (Fig. 1e, f). 
Furthermore, osteoclast function was determined by dentin resorption assays. 
Quantification of the area and the number of the pits revealed an antagonistic effect 
of the CM at higher concentration (Fig. 1g, h). These findings provide strong 
evidence that Mg2Ag degradation products inhibit osteoclast differentiation and 
function in vitro. 
 
3.3. Degradation of Mg2Ag implants in vivo 
 
3.3.1. Analysis of side effects 
 To determine if Mg2Ag implants cause adverse effects in vivo, Mg2Ag and steel 
pins were implanted into the right femur of mice. Compared to age matched mice that 
had no implant, mice that were implanted with Mg2Ag or steel pins did not show any 
abnormal activity or behavior (data not shown), or any difference in body weight over 
a period of 210 days (Fig. 2a). Various organs including liver, spleen, kidney and 
muscle were harvested for histological analysis 30 and 210 days after implantation. 
Consistent with the overall well being of all animals, no histological abnormalities 
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were observed in these organs of mice implanted with Mg2Ag pins compared to mice 
that received a steel pin or no implant (Fig. 2b). Taken together, these data indicate 
that the implantation of Mg2Ag pins into the medullary canal of the right femur does 
not cause measurable side effects on the growth rate or on inner organs morphology. 
 
3.3.2. Implant degradation in vivo 
 Next we sought to investigate the in vivo degradation of Mg2Ag pins after 
implantation into non-fractured femora of mice using X-ray and µCT analysis. 
Imaging by X-ray was performed immediately after surgery to confirm the correct 
positioning of the implant and after 30, 60 and 210 days to follow implant 
degradation. While all implants remained in their initial position without signs of 
loosening or displacement, a considerable degradation of Mg2Ag implants was 
appreciated 210 days after implantation (Fig. 3a). These data were then confirmed 
and further investigated by a higher resolution ex vivo µCT analysis 30, 60 and 210 
days after insertion of the implant. Degradation of the Mg2Ag implant was detectable 
already by day 30, continued by day 60 (Fig. 3b) and was almost completed by day 
210 (Fig. 3b, c). Interestingly, while the almost complete degradation of a Mg2Ag pin 
of 0.8 mm implanted into the medullary canal of a mouse femur takes approximately 
210 days, the time for the same implant to degrade in vitro was predicted to be 617 
days (see 3.1.2.) and therefore almost three times longer. We also noted that femora 
of animals of the Mg2Ag group appeared to have a widening of the femoral shaft 
compared to mice that received an intramedullary steel pin or no implant (Fig. 3b, c). 
To further investigate this interesting observation, femoral diameters at the midshaft 
were measured by µCT analysis. Indeed, intramedullary Mg2Ag pins significantly 
increased the femoral diameter compared to both control groups by about 40% (Fig. 
3c). 
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3.4. Effect of intramedullary Mg2Ag implants on fracture healing 
 
3.4.1. Exclusion of systemic adverse effects 
 First we wanted to test the hypothesis that Mg2Ag implants do not cause side 
effects during fracture healing. We therefore analyzed the body weight and the 
microscopic structure of liver, spleen, kidney and muscle obtained from mice that 
received a fracture fixation using an intramedullary Mg2Ag pin compared to control 
animals in which the fracture was stabilized by a steel implant. Quantification of the 
body weight showed an age-related increase 133 days after fracture without 
difference between groups, suggesting that intramedullary Mg2Ag implants do not 
affect animal growth under fracture conditions (Fig. 4a). This notion was further 
confirmed by histological analysis of various organs including liver, spleen, kidney 
and muscle at post-fracture day 7 and 133, which showed no histological abnormality 
of any organ of mice implanted with a Mg2Ag pin (Fig. 4b). These data confirm, that 
like under non-fracture conditions, intramedullary Mg2Ag pins do not cause acute or 
long-term systemic adverse effects. 
 
3.4.2. Imaging of implant position, degradation and fracture healing 
 Confirmation of the correct position of the intramedullary implant was performed by 
X-ray analysis immediately after implantation and on day 14, 21 and 133 (Fig. 5a). 
Using the same technique, mice were followed for up to 133 days after fracture, 
demonstrating the formation and remodeling of the callus in both groups and the 
degradation of the Mg2Ag implant during the course of the experiment (Fig. 5a). 
Next, we applied ex vivo µCT imaging as a method of higher sensitivity and 
resolution and found that the callus was fully developed already by day 14 in mice in 
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which the fracture was stabilized by a Mg2Ag pin, a time point at which callus 
formation just started to begin in the control group (Fig. 5b). Furthermore, callus 
formation was considerably stronger in response to Mg2Ag implants by day 21 while 
a complete fracture healing was observed in both groups (Fig. 5b). Interestingly, µCT 
imaging revealed an increase of the femoral midshaft diameter of 73 ± 6% in animals 
implanted with Mg2Ag pins compared to control animals at day 133 (Fig. 5c), 
suggesting that bone remodeling might be affected by Mg2Ag implants during 
fracture healing compared to steel pins. This increase in diameter of the femoral 
midshaft is consistent with the observation of a widening of the femoral shaft in 
response to Mg2Ag implants in non-fractured mice (Fig. 3c). However, the relative 
increase in diameter is greater in fractured compared to non-fractured bones. This 
indicates that intramedullary Mg2Ag implants might affect bone remodeling by 
influencing the activity of osteoclasts and osteoblasts and that this effect is 
augmented in the context of an activated bone remodeling during fracture healing. 
 
3.4.3. Analysis of callus formation, cartilage turnover and mineralization 
 Consistent with the finding made by µCT, histological analysis of mineralized 
tissue by day 14 and 21 after fracture confirmed the formation of a callus that was 
normally mineralized but augmented in mice, in which the long bone fracture had 
been stabilized by an intramedullary Mg2Ag implant compared to control animals 
(Fig. 6a). In both groups, fracture healing was completed successfully with a full 
removal of the callus by day 133 (Fig. 6a). To further characterize the influence of 
Mg2Ag implants on fracture repair, bones were investigated at early time points 
during fracture healing by dedicated histomorphometry. Fracture stabilization using a 
steel implant led to a significant increase in callus size between day 7 and day 14, 
followed by a decrease of the callus size between day 14 and day 21 (Fig. 6b). In 
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contrast, Mg2Ag implants led to a callus that was significantly larger compared to the 
control group as early as day 7 and at all subsequent points of analysis. Furthermore, 
the size of the callus did not decrease 14 days after fracture, demonstrating an 
augmented callus formation due to intramedullary Mg2Ag implants (Fig. 6b). 
 Fracture repair resembles endochondral ossification, a process during which 
cartilage tissue is formed and subsequently replaced by mineralized bone. To 
determine abnormalities in endochondral ossification in response to Mg2Ag implants, 
we quantified both the relative amount of cartilage and the relative amount of 
mineralized bone within the callus. In both groups, the amount of cartilage per callus 
was around 50% by day 7 and decreased during the following 2 weeks of fracture 
repair without major differences except for a greater decrease in cartilage by day 21 
in the group of mice that received Mg2Ag implants, suggesting a slightly increased 
turnover rate (Fig. 6c). Indicating an accelerated mineralization, by day 7 the relative 
amount of mineralized bone within the callus was significantly higher in mice in which 
fractures were stabilized by Mg2Ag implants compared to control animals (Fig. 6d). 
By day 14 and day 21, the amount of mineralized bone within the callus was 
significantly increased compared to day 7 with no differences among groups (Fig. 
6d). In summary, these data suggest that intramedullary Mg2Ag implants augment 
callus formation with an accelerated mineralization at the beginning of the fracture 
healing and an increased cartilage turnover towards the end of the remodeling 
phase. 
 
3.4.4. Quantification of bone formation and bone resorption 
 Next we sought to determine osteoblast activity on trabeculae of the fracture callus 
and at the periosteal elevation site after labeling of bone surfaces with calcein and 
demeclocycline at a defined time interval. Compared to fractures that were stabilized 
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with steel implants, the distance between the labels was greatly increased at the 
periosteal elevation site 21 days after fracture fixation using Mg2Ag pins and the 
newly produced bone matrix appeared as less organized woven bone, suggesting a 
highly activated osteoblast activity (Fig. 7a). Indeed, the mineral apposition rate 
(MAR), a parameter calculated from the distance of the labeled bone surfaces, was 
significantly increased in response to fracture stabilization by Mg2Ag implants 
compared to steel control pins at all time points investigated during 21 days of 
fracture healing (Fig. 7b). Analysis of bone formation on trabecular bone surfaces 
within the callus by day 21 after fracture also revealed an increased distance 
between fluorescent labels (Fig. 7c), representing a significantly increased bone 
formation rate per bone surface in response to Mg2Ag implants compared to control 
animals receiving steel implants (Fig. 7d). These data demonstrate that 
intramedullary Mg2Ag implants activate bone formation, leading to an increased 
callus formation. 
 Since Mg2Ag implants accelerated the mineralization of the newly formed callus at 
early stages (Fig. 6d), we speculated that despite the increased bone formation rate 
the amount of osteoid per bone surface might be unchanged, due to the rapid 
mineralization of the new matrix. Indeed, there was no difference in the amount of 
osteoid between both groups (Fig. 7e), demonstrating the fast incorporation of 
minerals into the matrix in response to Mg2Ag implants. Furthermore, the number of 
osteoblasts was unaffected by Mg2Ag pins compared to control (Fig. 7f), further 
supporting the notion of an increased rate of bone-matrix production that undergoes 
rapid mineralization. 
 Bone resorption is an integral component of bone remodeling during fracture 
repair. Since in vitro analyses revealed that Mg2Ag degradation products inhibited 
osteoclast differentiation and function (Fig. 1e-f), we hypothesized that bone 
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resorption could be compromised in vivo during fracture healing in response to 
intramedullary Mg2Ag implants. To address this question we quantified the amount of 
eroded surface per bone surface and determined the number of osteoclasts per bone 
surface. Consistent with the in vitro findings, we observed that intramedullary Mg2Ag 
implants significantly decreased both bone resorption (Fig. 7g) reflecting osteoclast 
activity and the number of osteoclasts (Fig 7h). The reduction in bone resorption 
therefore contributes to the augmented callus formation by intramedullary Mg2Ag 
implants during fracture healing in mice. 
 
4. Discussion 
 Intramedullary nailing is frequently used to stabilize long bone fractures [2]. After 
fracture healing, the nail usually remains but under certain circumstances such as 
pain or the need for another implant, removal of the intramedullary nail might become 
necessary [4,5]. Thus, biodegradable materials, including Mg-alloys, are promising 
alternatives that could obviate the need for implant removal [8,9,13,20]. Although Mg-
based implants have a long history in musculoskeletal research [7], degradation, 
biocompatibility and the influence on bone tissue of intramedullary Mg2Ag nails 
under steady state and fracture conditions has not yet been investigated. To address 
these questions, we used intact, i.e. non-fractured, mouse femora and an open 
midshaft bi-cortical femoral fracture model in mice. Prior to analyzing this in vivo 
system, we performed in vitro experiments to determine the degradation of the 
Mg2Ag alloy, which was calculated to require about 1.7 years for the implant to fully 
degrade without affecting the osmolality or the pH of the environment. Compared to 
other Mg-based alloys, this degradation rate is rather slow and favorable for a 
potential use as bone implants [21,22]. As a prerequisite for bone implants, the 
Mg2Ag alloy should not cause any effects on bone cells that could compromise 
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fracture healing. We therefore investigated the influence of medium enriched with 
products resulting from the degradation of Mg2Ag on osteoblasts and osteoclasts. 
Our results demonstrate that osteoblast differentiation was unaffected by medium 
containing Mg2Ag degradation products, while osteoclast differentiation and function 
was greatly inhibited in a dose-dependent manner. These findings are consistent with 
those reported by others and are in support of further investigating this novel material 
in musculoskeletal research [25,26,31]. 
 Next, we implanted custom-made intramedullary Mg2Ag nails of 0.8 mm diameter 
into non-fractured femora of adult mice. Imaging analysis using x-ray and µCT 
revealed that the implants were almost entirely degraded after 210 days, which is 
about three times faster than the degradation rate determined in vitro. Discrepancies 
between in vitro and in vivo degradation rates have been reported previously and 
emphasize the importance of in vivo degradation studies since a plethora of 
environmental cues including cell-based influences of the bone marrow environment, 
mechanical stimulation or continuous exchange of the liquids surrounding the implant 
may affect the degradation of the implant [32]. Nevertheless, the in vivo degradation 
of Mg2Ag intramedullary nails reported here occurs at a rate that provides sufficient 
mechanical stability while supporting fracture healing. 
 Neither under non-fracture nor under fracture conditions systemic adverse effects 
caused by Mg2Ag implants were observed based on a stable body weight of the 
experimental animals and a normal histological appearance of various inner organs 
at different time points. Consistent with our observations, others reported that the 
implantation of a Mg-Y-Zn alloy into pigs did not result in any systemic side effects, 
demonstrating high biocompatibility of the material [33]. In addition, implantation of a 
Mg-Y-Nd alloy containing heavy rare-earth elements into rats showed no systemic 
inflammatory reactions in blood smears of operated animals [34]. Thus, the findings 
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reported by others and the results shown here support the notion that Mg-based 
implants do not cause deleterious effects on animal growth or on inner organs. 
 Dedicated histomorphometric analysis of fracture healing revealed an increase in 
osteoblast activity, which led to an augmented bone formation rate and subsequent 
enhanced callus production. Early mineralization of the callus was enhanced and 
then continued normally. Furthermore, the Mg2Ag alloy reduced the number and 
activity of osteoclasts, a finding that is consistent with our in vitro observations and 
with the results reported by others [26,31,35]. Thus, the increased callus formation 
mediated by intramedullary Mg2Ag implants during fracture healing in mice is 
probably due to both an increase in bone formation and a decrease in bone 
resorption. These findings therefore strongly suggest the suitability of degradable 
Mg2Ag implants to promote long bone fracture healing in mice and are consistent 
with studies reporting positive effects of Mg implants on osteoblasts and bone 
formation [12–14,31,36,37]. However, we also noticed that Mg2Ag implants caused 
alterations of the shape of long bones under non-fracture and fracture conditions. 
Mg2Ag nails induced a widening of the femoral shaft without an obvious effect on the 
thickness of the cortical bone. We assume that these changes in bone shape are, at 
least in part, a consequence of the disturbed bone remodeling with an enhanced 
bone formation and an attenuated bone resorption, leading to an unbalanced 
turnover of the entire bone. Nevertheless, these findings require continued 
investigations in subsequent studies to further determine the suitability of 
biodegradable Mg2Ag alloys as material for intramedullary nails to treat long bone 
fractures. 
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5. Conclusions 
 Our study demonstrates that Mg2Ag-based intramedullary nails are suitable 
implants for the fixation of femoral fractures in mice. The material stimulated bone 
formation while inhibiting bone resorption, leading to an augmented callus formation 
during fracture healing. Mg2Ag implants degraded within a reasonable period of time 
without causing systemic adverse effects. Thus, Mg2Ag might be a promising 
material to be further investigated for potential applications in musculoskeletal 
medicine. 
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Figure Legends 
Fig. 1. (a) Surface analysis of Mg2Ag implant prior to degradation (day 0, upper 
panel) and during degradation (day 7, lower panel) in cell culture medium (scale bar 
= 0.8 mm). Change of osmolality (b) and pH (c) of the medium during degradation. 
Graphs show mean values ± SEM, n = 6. Analysis of osteoblast and osteoclast 
differentiation in the presence of conditioned medium (CM) containing an increasing 
concentration of Mg2Ag degradation products. (d) Alkaline phosphatase staining of 
osteoblasts on day 7 (scale bar = 100 µm). (e) Tartrate-resistant acid phosphatase 
(TRAP) staining of osteoclasts on day 4 (scale bar = 100 µm), blue arrows: mono-
nucleated TRAP-positive osteoclast precursors, black arrows: multi-nucleated TRAP-
positive mature osteoclasts. (f) Quantification of the number and the size of 
osteoclasts. (g) Resorption pits on dentin 6 days after plating of osteoclast precursors 
(scale bar = 50 µm). (h) Quantification of the area and the number of the resorption 
pits. (d, e, g) Representative images of 4 independent experiments. (f, h) Graphs 
show mean ± SEM, n = 9 samples per group, * = p ≤ 0.05, ** = p ≤ 0.001, significant 
compared to the groups that were treated with control medium. 
 
Fig. 2. (a) Quantification of body weight of mice after implantation of Mg2Ag pins 
compared to mice receiving a steel implant or no implant as control. Graph shows 
mean values ± SEM, n = 4 animals per group. (b) Representative images of 
hematoxylin & eosin-stained sections of liver, spleen, kidney and muscle at day 30 
and day 210 after implantation of a Mg2Ag pin compared to mice that received a 
steel pin or no implant as control, 20x magnification (scale bar = 100 µm), small 
boxes = area of digital magnification, large boxes: 13.5x digital zoom. 
 
  
 23
Fig. 3. Bone morphology and implant degradation of mice implanted with Mg2Ag pins 
without fracture compared to steel pins and no implant control. Representative (a) X-
ray images (scale bar = 5 mm), (b) µCT images of femora over time in animals with 
steel or Mg2Ag implants compared to no implant control (scale bar = 2 mm), white 
arrow indicates degradation of the Mg2Ag pin, (c) µCT images of femoral midshaft 
cross sections at day 210 (scale bar = 0.5 mm), numbers indicate the width of the 
shaft diameter relative to no implant control ± SEM. N = 4 animals per group, p ≤ 
0.05, *significant compared to the group that received steel implants. 
 
Fig. 4. (a) Quantification of body weight during 133 days after fracture fixation using 
an intramedullary Mg2Ag pin or a steel implant as control. Graph shows mean values 
± SEM, n = 6-11 animals per group. (b) Representative images of hematoxylin & 
eosin-stained sections of liver, spleen, kidney and muscle at day 7 and day 133 after 
fracture and implantation of a Mg2Ag pin compared to mice that received a steel pin 
as control, 20x magnification (scale bar = 100µm), small boxes = area of digital 
magnification, large boxes: 13.5x digital zoom. 
 
Fig. 5. Representative (a) X-ray images to determine implant positioning, callus 
formation and degradation of intramedullary Mg2Ag pins (scale bar = 5 mm), (b) µCT 
images of callus formation and fracture healing during 133 days in mice after fracture 
stabilization using a Mg2Ag implant compared to a steel pin as control (scale bar = 2 
mm), (c) µCT images of cross sections of the femoral mid-shaft at day 133 post 
fracture (scale bar = 0.5 mm), numbers indicate the width of the shaft diameter 
relative to the control group that received steel implants ± SEM. N = 7-14 animals per 
group, p ≤ 0.05, *significant compared to the group that received steel implants. 
 
  
 24
Fig. 6. (a) Representative images of mineralized bones on day 14, day 21 and day 
133 after fracture stabilization using an intramedullary Mg2Ag pin or a steel implant, 
von Kossa/van Gieson staining (scale bar = 2 mm). (b) Quantification of the callus 
area, (c) relative amount of cartilage within the callus and (d) relative amount of 
mineralized bone within the callus during a time-course of 21 days after fracture 
stabilization using an intramedullary Mg2Ag pin or a steel implant. Graphs show 
mean ± SEM, n = 6-11 animals per group, p ≤ 0.05, *significant compared to mice 
that received steel implants, #significant compared to day 7, +significant compared to 
day 14. 
 
Fig. 7. (a) Representative images of calcein/demeclocycline labeling at the periosteal 
elevation site on day 21 after fracture stabilization using an intramedullary Mg2Ag pin 
or a steel implant (scale bar = 20 µm). (b) Quantification of the periosteal mineral 
apposition rate (Ps MAR) at the same site on day 7, day 14 and day 21 after fracture 
stabilization. (c) Representative images of double labeling of trabecular bone 
surfaces within the callus by day 21 after fracture stabilization (scale bar = 20 µm). 
Quantification of (d) the bone formation rate / bone surface (BFR/BS), (e) the osteoid 
surface / bone surface (OS/BS), (f) the number of osteoblasts / bone surface 
(N.Ob/BS), (g) the eroded surface / bone surface (ES/BS), and (h) the number of 
osteoclasts / bone surface (N.Oc/BS) at the same site on day 21 after fracture 
stabilization using Mg2Ag pins or steel implants. Graphs show mean ± SEM, n = 6-11 
animals per group, p ≤ 0.05, *significant compared to the group that received steel 
implants.  
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Statement of Significance 
Biodegradable implants are promising alternatives to standard steel or titanium implants 
to avoid implant removal after fracture healing. We therefore developed an intramedullary 
nail using a novel biodegradable magnesium-silver-alloy (Mg2Ag) and investigated the in 
vitro and in vivo effects of the implants on bone remodeling under steady state and 
fracture healing conditions in mice. Our results demonstrate that intramedullary Mg2Ag 
nails degrade in vivo over time without causing adverse effects. Importantly, radiographs, 
μCT and bone histomorphometry revealed a significant increase in callus size due to an 
augmented bone formation rate and a reduced bone resorption in fractures supported by 
Mg2Ag nails, thereby improving bone healing. Thus, intramedullary Mg2Ag nails are 
promising biomaterials for fracture healing to circumvent implant removal. 
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